NCT06523582View on ClinicalTrials.gov

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

RecruitingOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

August 3, 2022

Primary Completion Date

March 1, 2037

Study Completion Date

March 1, 2037

Conditions
Neuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of LungThymic Neuroendocrine NeoplasmNeuroendocrine Tumor of PancreasGastrointestinal Stromal TumorsMedullary Thyroid CancerParagangliomaPheochromocytomaPrimary HyperparathyroidismPituitary TumorMultiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2Multiple Endocrine Neoplasia Type 4Carney ComplexCarney Stratakis DyadCarney TriadCowden SyndromeDICER1 SyndromeLi-Fraumeni SyndromeLynch SyndromeVon Hippel-Lindau DiseaseFamilial Isolated Pituitary AdenomaX-Linked AcrogigantismNeurofibromatosis 1Tuberous Sclerosis
Trial Locations (3)

14080

RECRUITING

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City

RECRUITING

Red de Apoyo a la Investigación, Coordinación de la Investigación Científica, Universidad Nacional Autónoma de México, Mexico City

06720

RECRUITING

Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City

All Listed Sponsors
collaborator

Instituto Mexicano del Seguro Social

OTHER_GOV

collaborator

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

OTHER

lead

Universidad Nacional Autonoma de Mexico

OTHER